This project will determine how oxidative stress and cellular metabolism maintain the pathogenic activation of synovial fibroblasts. It will test whether redox-modulating compounds can reverse inflammatory priming and restore a pro-resolving tissue state. The project is likely to involve experimental disease models in mice. Previous experience with mouse work would therefore be advantageous, although it is not an essential eligibility criterion.